Hong Kong-listed CSPC Pharmaceutical said on Thursday it would buy back shares worth up to HK$5 billion ($640 million) in the ...

This summary presents key updates in the health sector. Highlights include UnitedHealth's tech unit customers adopting ...

This health news summary covers significant topics including UnitedHealth tech unit's post-hack customer situation, new ...

Three Chinese companies - Walvax Biotechnology, CSPC Pharmaceutical Group and Stemirna Therapeutics - came up with mRNA vaccines that won limited emergency approvals in Asia. However, Walvax and ...

Omalizumab Biosimilar is a monoclonal antibody commercialized by CSPC Pharmaceutical Group, with a leading Phase III program in Rhinosinusitis.

Three Chinese companies - Walvax Biotechnology, CSPC Pharmaceutical Group and Stemirna Therapeutics - came up with mRNA vaccines that won limited emergency approvals in Asia. However, Walvax and ...

CMB International Securities analyst Jill Wu maintained a Buy rating on CSPC Pharmaceutical Group (CHJTF – Research Report) on August 23 and set a price target of HK$6.21. Jill Wu’s rating is ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Hong Kong-listed CSPC Pharmaceutical said on Thursday it would buy back shares worth up to HK$5 billion ($640 million) in the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

OPHLYOno Pharmaceutical Co., Ltd.